An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Vendors market the drug there before directing buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Express Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.
Some experts said the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.
Service Response and Material Removal
According to the social media company, the service has removed problematic content and prohibited related hashtags and query recommendations. The company said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.
Online Trading Activities
Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, populated with images of weight loss, positive reviews and detailed guides for mixing or administering at home.
After minutes of joining one community, a vendor shared contact information, where most purchases take place. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.
Item Details and Costs
Inside these groups, posts show dark colored parcels with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they can’t verify. Although the science behind this drug is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.
Her team has previously seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational substance not yet approved … may expose users to possibly serious medical dangers”.
